Top Markets
Coin of the day
SynAct Pharma AB SynAct Pharma AB

SynAct Pharma AB

SYNACT
Rang in Aktien #21155
SynAct Pharma AB, operating through its subsidiary SynAct Pharma ApS,... SynAct Pharma AB, operating through its subsidiary SynAct Pharma ApS, specializes in creating pharmaceutical interventions for the acute exacerbation of inflammatory conditions. The company's primary investigational compound, AP1189, is currently being developed for the treatment of both rheumatoid arthritis and idiopathic membranous glomerulonephritis. Additionally, SynAct Pharma maintains a collaborative research initiative with the University of Örebro, focusing on the mitigation of inflammation in vascular diseases. Established in 2012, the firm's corporate headquarters are situated in Lund, Sweden.
Aktienkurs
$2.13
Marktkapitalisierung
$113.07M
Veränderung (1 Tag)
-3.93%
Veränderung (1 Jahr)
12.65%
Land
SE
Handel SynAct Pharma AB (SYNACT)

Kategorie

Kursverlauf für SynAct Pharma AB (SYNACT)
Höchster Schlusskurs: $2.19 am 2026-08-01

Niedrigster Schlusskurs: $0.56 am 2016-07-01
Kursverlauf der Aktie von SynAct Pharma AB von 2016 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) -7.35%
2025 144.78%
2024 17.64%
2023 -89.62%
2022 -48.77%
2021 236.22%
2020 376.82%
2019 16.49%
2018 -27.27%
2017 82.38%
2016 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$547.71 38.62%
US
$1.04K 58.06%
NL
$145.75 437.43%
US
$119.27 -15.19%
AU
$766.29 8.42%
CH